Glatt. Integrated Process Solutions.
Worldwide.
Worldwide.
In addition to its expertise as a plant manufacturer and specialist for particle design in the non-pharmaceutical environment, Glatt is an established market player for engineering services for the pharmaceutical industry.
For more than 30 years, we have created corresponding references with and for our customers. For us, integrated solutions for your projects mean not only the execution of planning tasks, but also the overall realisation of solutions.
In addition to our many years of engineering experience, you can benefit from the synergies of our group of companies through the various areas of expertise.
The cross-industry exchange of experience within the Glatt Group creates an innovative environment for optimal, customised solutions in product and process development, plant engineering and contract manufacturing. All Glatt customers benefit from the multitude and diversity of topics that provide new impetus and pave the way for new technologies. GxP for the pharmaceutical environment and HACCP for the food sector are not opposites, but the profession in which we operate on a daily basis.
Existing structures for technical purchasing and the installation of planned systems or system components for projects in the food, feed and fine chemical environment are also available for your projects. This means that, if required, you not only receive a engineering service, but really integrated project solutions from A to Z.
For pharmaceutical applications, Glatt Pharmaceutical Services complements the development of solid dosage forms. With systems from Glatt Process Technology Pharma for pharmaceutical bulk production and systems for liquid production from our subsidiary GSPL in India, we provide a portfolio that is unique as a supply chain.
The international Glatt Group has a global network of around 3,000 employees. Numerous representatives are available worldwide as contacts for the complete range of services.
Learn more about Glatt. Integrated Process Solutions.
ISPE. RAYA 2023 Winner Audience Award
The objective of this robot application is to achieve a full automation of typically manual supported pharmaceutical production processes by combining common process equipment with robot arms!
Further information on this topic and related topics can also be found in the following publications:
December 2023: Glatt wins follow-up order for BioCampus MultiPilot in the port of Straubing-Sand
June 2023: ‘Glatt joins forces with Merck for cosmetic pigment production’
Published article: ‘Outsourcing – Trust in competent partners’ PDF, English
Published article: ‘Containment solutions only cost-effective when adapted’ PDF, English